SPRB
SPRUCE BIOSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$40.40
+1.89%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-61.3%
Return on equity
-49.9%
Return on assets
-52.3%
Return on invested capital
0.00x
Asset turnover
-$42.6M
Cash from operations
$34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026